Back to Search
Start Over
Features of Mild-to-Moderate COVID-19 Patients With Dysphonia
- Source :
- Journal of Voice, Journal of Voice, 2020, 36 (2), pp.249-255. ⟨10.1016/j.jvoice.2020.05.012⟩, Journal of Voice, Elsevier, 2020, ⟨10.1016/j.jvoice.2020.05.012⟩
- Publication Year :
- 2022
-
Abstract
- International audience; Introduction: To explore the prevalence of dysphonia in European patients with mild-to-moderate COVID-19 and the clinical features of dysphonic patients.Methods: The clinical and epidemiological data of 702 patients with mild-to-moderate COVID-19 were collected from 19 European Hospitals. The following data were extracted: age, sex, ethnicity, tobacco consumption, comorbidities, general, and otolaryngological symptoms. Dysphonia and otolaryngological symptoms were self-assessed through a 4-point scale. The prevalence of dysphonia, as part of the COVID-19 symptoms, was assessed. The outcomes were compared between dysphonic and nondysphonic patients. The association between dysphonia severity and outcomes was studied through Bayesian analysis.Results: A total of 188 patients were dysphonic, accounting for 26.8% of cases. Females developed more frequently dysphonia than males (P = 0.022). The proportion of smokers was significantly higher in the dysphonic group (P = 0.042). The prevalence of the following symptoms was higher in dysphonic patients compared with nondysphonic patients: cough, chest pain, sticky sputum, arthralgia, diarrhea, headache, fatigue, nausea, and vomiting. The severity of dyspnea, dysphagia, ear pain, face pain, throat pain, and nasal obstruction was higher in dysphonic group compared with nondysphonic group. There were significant associations between the severity of dysphonia, dysphagia, and cough.Conclusion: Dysphonia may be encountered in a quarter of patients with mild-to-moderate COVID-19 and should be considered as a symptom list of the infection. Dysphonic COVID-19 patients are more symptomatic than nondysphonic individuals. Future studies are needed to investigate the relevance of dysphonia in the COVID-19 clinical presentation.
- Subjects :
- Male
medicine.medical_specialty
Nausea
[SDV]Life Sciences [q-bio]
ENT
Dysphonia, Covid-19, Coronavirus, Voice, Symptoms, Clinical, Findings, ENT
Chest pain
Article
030507 speech-language pathology & audiology
03 medical and health sciences
Speech and Hearing
Clinical
0302 clinical medicine
Throat
Internal medicine
Epidemiology
medicine
Prevalence
otorhinolaryngologic diseases
Humans
Dysphonia−Covid-19−Coronavirus−Voice−Symptoms−Clinical−Findings−ENT
030223 otorhinolaryngology
Hoarseness
business.industry
COVID-19
Bayes Theorem
Findings
LPN and LVN
Dysphonia
Dysphagia
3. Good health
Coronavirus
Diarrhea
medicine.anatomical_structure
Otorhinolaryngology
Symptoms
Vomiting
Voice
Sputum
Female
medicine.symptom
0305 other medical science
business
Covid-19
Subjects
Details
- Language :
- English
- ISSN :
- 08921997
- Database :
- OpenAIRE
- Journal :
- Journal of Voice, Journal of Voice, 2020, 36 (2), pp.249-255. ⟨10.1016/j.jvoice.2020.05.012⟩, Journal of Voice, Elsevier, 2020, ⟨10.1016/j.jvoice.2020.05.012⟩
- Accession number :
- edsair.doi.dedup.....82d6e83a62c4c0a80dba8cbad89eb405